Emerging Trends in the Delivery of Resveratrol by Nanostructures: Applications of Nanotechnology in Life Sciences

Table 2

Nanoparticle-based systems reported for resveratrol.

Type of nanoparticulate systems	Drug/s	Disease targeted	References
Chitosan-coated NPs	Resveratrol	Lung cancer	[119]
Alginate NPs	Curcumin and resveratrol	Prostate cancer	[120]
Gelatin-coated NPs	Resveratrol	Lung cancer	[121]
Mesoporous silica NPs	Resveratrol	Melanoma	[122]
Solid lipid NPs	Resveratrol	Contact dermatitis	[123]
Oxidized mesoporous carbon NPs	Resveratrol	Triple negative breast cancer	[124]
Super paramagnetic iron oxide NPs	Resveratrol	Glioma	[125]
Solid lipid NPs	Curcumin and resveratrol	Colorectal cancer	[126]
Solid-lipid microparticulate	Resveratrol	Melanoma	[127]
Lipid-core nanocapsules	Curcumin and resveratrol	Human skin disease	[128]
Galactosylated NPs	Resveratrol	Anti-inflammatory	[129]
PEG-PLGA NPs	Resveratrol	Liver cancer	[130]
Hyaluronic acid-functionalized chitosan nanoparticles	Curcumin and resveratrol	Diabetic wound	[131]
Poly (D,L-lactide-co-glycolide)-D-α-tocopheryl polyethylene glycol 1000 succinate blend NPs	Resveratrol	Glioma	[132]
Silk fibrin-coated NPs	Resveratrol	Inflammatory bowel disease	[133]
Mesoporous silica nanoparticles (MSNPs)	Anti-miR21 and resveratrol	Gastric carcinoma	[134]
Hepatic-targeted oxidized starch-lysozyme (OSL) nanocarriers	Resveratrol	Nonalcoholic fatty liver disease	[135]
Ethanol extract of Angelica gigas Nakai- (AGN Ex-) based NPs	Resveratrol	Ovarian cancer	[136]
Glyceryl behenate or polyoxyethylene 40 stearate-based lipid carriers	Resveratrol	Hyperpigmentation and melanogenesis	[137]
Chitosan-coated SLNs	Resveratrol (RSV) and ferulic acid	Colon cancer	[138]
Technetium-99 m labeled gold NPs	Resveratrol	Colon cancer	[139]
Polyethylene glycol-polylactic acid (PEG–PLA; M.W. 5000-5000) polymer NPs	Resveratrol	Colon cancer	[140]
Solid lipid NPs	Omega-3 PUFA and resveratrol	Colon cancer	[141]